World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
J Glob Antimicrob Resist. 2019 Mar;16:17-27. doi: 10.1016/j.jgar.2018.08.014. Epub 2018 Aug 23.
Published literature on methicillin-resistant Staphylococcus aureus (MRSA) in the Asia-Pacific region was reviewed to document the prevalence of MRSA in the region and to examine the impact of variability in study design on the reported MRSA prevalence data.
This review included studies reporting MRSA prevalence between 2000 and 2016. Studies were excluded if they did not contain complete information on antimicrobial susceptibility testing (AST) methods. Primary outcomes were the proportion of MRSA among S. aureus isolates (resistance proportion) or among individual samples (prevalence).
A total of 229 studies in 19 countries/territories were included in the study. There was substantial heterogeneity in both outcomes (resistance proportion, I=99.59%; prevalence, I=99.83%), precluding pooled averages, and meta-regression analyses revealed that these variations were explained by country income status and participant characteristics but not by methodological differences in AST. Also, no significant secular changes in MRSA prevalence or resistance proportions in Asia-Pacific were found.
The resistance proportions and prevalence of MRSA infections in Asia-Pacific are comparable with those reported in other regions with no significant secular changes in the past decade. Country income status and characteristics of the sample population explained more variation in the reported resistance proportions and prevalence of MRSA than methodological differences in AST across locations in the region.
本研究回顾了亚太地区耐甲氧西林金黄色葡萄球菌(MRSA)的文献,以记录该地区 MRSA 的流行情况,并考察研究设计的变异性对报告的 MRSA 流行数据的影响。
本综述纳入了 2000 年至 2016 年间报告 MRSA 流行率的研究。如果研究未包含关于抗菌药物敏感性检测(AST)方法的完整信息,则将其排除。主要结局是金黄色葡萄球菌分离株(耐药率)或单个样本(流行率)中 MRSA 的比例。
共纳入来自 19 个国家/地区的 229 项研究。两种结局(耐药率,I=99.59%;流行率,I=99.83%)均存在显著异质性,无法进行汇总平均,荟萃回归分析显示,这些差异由国家收入状况和参与者特征解释,但与 AST 方法学差异无关。此外,在过去十年中,亚太地区未发现 MRSA 流行率或耐药率的显著季节性变化。报告的 MRSA 耐药率和流行率与其他地区相当,而地区内不同地点 AST 方法学差异对报告的耐药率和流行率的变异解释作用较小。
亚太地区 MRSA 感染的耐药率和流行率与其他地区相当,在过去十年中未发现明显的季节性变化。国家收入状况和样本人群特征比地区内不同地点 AST 方法学差异更能解释报告的 MRSA 耐药率和流行率的变异性。